They called for stability and predictability at the agency at Axios' Future of Health summit.

Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.

Leaders want the next FDA commissioner to be someone who can rebuild trust, focus on food policy, and drive drug-approval reforms.

They called for stability and predictability at the agency at Axios' Future of Health summit.

With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across biopharma have joined in support of the FDA’s former top…

Marty Makary is out, and the Trump administration has a long wish list for its next FDA commissioner.